Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.38B |
| 2 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$685M |
| 3 |
Home Depot
HD
|
+$497M |
| 4 |
Bausch Health
BHC
|
+$314M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$418M |
| 2 |
AT&T
T
|
+$243M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$193M |
| 4 |
Southern Company
SO
|
+$163M |
| 5 |
DELL
DELL INC
DELL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.21% |
| 2 | Financials | 5.16% |
| 3 | Technology | 4.66% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Energy | 3.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Integra LifeSciences
IART
$1.33B
| $968K | ﹤0.01% |
50,400
+6,376
| +14% | +$117K |
|
|
WMC
3377
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $968K | ﹤0.01% |
6,903
+6,401
| +1,275% | +$1.03M |
|
3378
Ambarella
AMBA
$3.81B
| $967K | ﹤0.01% |
+29,058
| New | +$667K |
|
|
XEC
3379
CALL
DELISTED
CIMAREX ENERGY CO
XEC
| $967K | ﹤0.01% |
9,300
+6,200
| +200% | +$628K |
|
|
MMT
3380
Aberdeen Multi-Market Income Fund
MMT
$241M
| $963K | ﹤0.01% |
160,527
+20,217
| +14% | +$132K |
|
3381
PUT
Beazer Homes USA
BZH
$906M
| $962K | ﹤0.01% |
40,100
-53,600
| -57% | -$1.06M |
|
3382
PUT
United States Gasoline Fund
UGA
$124M
| $962K | ﹤0.01% |
16,300
-8,100
| -33% | -$463K |
|
3383
Itron
ITRI
$4.52B
| $961K | ﹤0.01% |
23,447
+3,032
| +15% | +$129K |
|
|
PIM
3384
Franklin Master Intermediate Income Trust
PIM
$151M
| $961K | ﹤0.01% |
192,122
+47,208
| +33% | +$235K |
|
|
MGLN
3385
DELISTED
Magellan Health Services, Inc.
MGLN
| $961K | ﹤0.01% |
16,279
-10,347
| -39% | -$618K |
|
3386
Universal Corp
UVV
$1.26B
| $960K | ﹤0.01% |
17,766
-6,587
| -27% | -$342K |
|
|
USG
3387
DELISTED
Usg
USG
| $956K | ﹤0.01% |
34,204
-2,186
| -6% | -$59.2K |
|
|
BCF
3388
DELISTED
BLACKROCK REAL ASSET EQUITY TRUST
BCF
| $956K | ﹤0.01% |
119,476
+45,494
| +61% | +$402K |
|
3389
BlackRock Multi-Sector Income Trust
BIT
$702M
| $952K | ﹤0.01% |
+56,000
| New | +$939K |
|
|
ROSE
3390
DELISTED
ROSETTA RESOURCES INC
ROSE
| $951K | ﹤0.01% |
19,852
-39,336
| -66% | -$2.12M |
|
|
ATCO
3391
CALL
DELISTED
Atlas Corp.
ATCO
| $950K | ﹤0.01% |
43,200
+39,600
| +1,100% | +$885K |
|
|
GLBR
3392
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $950K | ﹤0.01% |
5,588
+1,002
| +22% | +$168K |
|
3393
CALL
America Movil
AMX
$71.4B
| $948K | ﹤0.01% |
41,200
-28,900
| -41% | -$630K |
|
3394
RH
RH
$3.69B
| $948K | ﹤0.01% |
14,153
+1,900
| +16% | +$130K |
|
|
PTR
3395
CALL
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $948K | ﹤0.01% |
8,700
+6,000
| +222% | +$686K |
|
|
ICPT
3396
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $947K | ﹤0.01% |
13,931
+11,343
| +438% | +$655K |
|
|
KSU
3397
PUT
DELISTED
Kansas City Southern
KSU
| $947K | ﹤0.01% |
7,700
+800
| +12% | +$95.7K |
|
3398
CALL
SM Energy
SM
$6.99B
| $946K | ﹤0.01% |
11,400
-13,400
| -54% | -$1.14M |
|
|
MCP
3399
PUT
DELISTED
MOLYCORP INC COM STK
MCP
| $944K | ﹤0.01% |
188,700
-79,700
| -30% | -$421K |
|
3400
CALL
KeyCorp
KEY
$24.4B
| $943K | ﹤0.01% |
72,500
-246,800
| -77% | -$3.12M |
|
Similar funds
Barclays's Q4 2013 Portfolio in Review
As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $6.87B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.
By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.
- Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
- Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
- Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
- Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
- Barclays opened 582 new positions and closed 442 in Q4 2013.
- Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.
Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.